Versions Compared


  • This line was added.
  • This line was removed.
  • Formatting was changed.




Impact assessment of the estimands framework and recommendations/best practices (where applicable) for implementing the framework in the following areas:

  • Data Collect Design/CDASH
  • SDTM
  • ADaM (including handling of intercurrent events, missing data imputation) – Analysis Displays
  • cSDRG and ADRG

Development of new standards is not in scope, and any impact findings that may necessitate new standard development will be shared with CDISC for their consideration. Examples may be created on how to implement the framework by using permitted extensions to the existing data standards.

Project LeadsEmail
Chris Price
, Roche

Lori VanMeter
, Johnson & Johnson
Katie Warren (
Nicola Newton, PHUSE Project Assistant

.Objectives & DeliverablesTimelines

Kick off

Q1 2022

Review current company practices 

Q1 2022

Develop conference abstract 

Q2 2022

Draft paper

Q3 2022 

Conference slides 

Q4 2022

Final paper for public review

Q4 2022

Final paper published

Q1 2023



Project approved




  • Completed public review of White Paper
  • Great interest in paper as received over 400 public comments
  • Collaborating with EIWG statisticians to align white paper recommendations
  • Poster session at the US Connect and presentation at International Society for Biopharmaceutical Statistics (ISBS) 2024

Objectives & DeliverablesTimelines

Submit abstracts for multiple conferences 

Q2 2023

Develop draft White Paper for internal project review prior to PHUSE Working Group Review and Public Review

Q3 2023

 Final White Paper

Q1 2024
Project MembersOrganisation Ann M Pennington Pfizer Arman SabbaghiPurdue UniversityArmin SchuelerMerckgroup Banoo Madhanagopal Bayer 

Benoît Sansas

Pierre FabreBess LeroyCDISCCedric Davister MerckDong Xi Gilead Edwin van SteinGSKElena PolverejanJanssen Research & Development Emilea Norris CDISCJennifer, BrittGileadJohn ScottFDAJonathan Siegel Bayer Jozef AertsXML4PharmaJunxiang LuoModerna Kevin LiuPfizer Kim Musgrave AmgenLiping SunFDALisa LinFDAMarc Walton Janssen Research & Development Matt Baldwin AmgenMindy Mo BayerMunish MehraTigermedNilani Liyanage Jansen Research & Development Oliver Wirtz Bayer Rama Empati AstraZenecaRhian Jacob- Moffatt RocheRobin WhiteEli Lilly and CompanyRosanne LaneJanssen Research & Development Santosh K Lingala Gilead Shahida Tamboli Labcorp Stephen Ruberg Analytix ThinkingSteve Gilbert Pfizer Steve WilsonFDASujitha Susan JohnNovo Nordsik Vidya Jayapalan TakedaXiaohan ZouBristol Myers SquibbYongming QuEli Lilly Yun Peng Bristol Myers Squibb